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Introduction: Thalassemia patient lifespan nowadays has been increased 
significantly compared previously due to the advancement of medical treatment 
and better healthcare system. As a result, more transfusion-related complication 
has been seen, and one of the rising trends was the thromboembolic complication. 
Studies had shown that ultrasound measurement of carotid artery intima media 
thickness (CIMT) can be used as a surrogate marker for future cardiovascular 
event and is recommended to be done in t halassemia patient as early diagnostic 
tool and for vascular risk stratification.  
 
Objectives: The aim of this study were to compare the CIMT value between 
thalassemia patients and normal population and to find any correlation between 
thalassemia CIMT measurement with patient’s age, disease duration, number of 
blood transfusion and serum ferritin levels.   
Methods: All thalassemia patient attending treatment and follow-up at HUSM 
who fulfilled the inclusion criteria were recruited. An equal number of healthy 
subjects (gender matched) were taken as control group. Subjects from both 
groups with hypertension, diabetes mellitus, hypercholesterolemia, metabolic or 
connective tissue disease, on oral anti- coagulant, oral contraceptive pills, bed 
ridden and smoker were excluded. The CIMT measurement was performed by a 
single operator using an ultrasound machine (Siemen Acuson S2000) with 18 
MHz linear array transducer. Both side of carotid arteries examination was 
performed with the subject in lying positioned and after a 10 minutes rest. An 
independent T-test was performed to compare mean. Regression analysis was 
used to look for association between CIMT and patient’s age, disease duration, 
number of bood transfusion and serum ferittin level. All data analysis was 
performed using IBM SPSS software version 22.0 for Windows. 
 
Results. A total of 80 subjects were included in this study with the equal 
number of thalassemia patients and the normal population. The mean value of 
CIMT of the general population was 0.32± 0.08mm and the mean value of 
thalassemia patient’s CIMT was 0.45± 0.10mm. The independent t-test showed 
statistically significant differences of these measurement (p<0.001). On univariate 
analysis, there is a strong correlation between thalassemia CIMT measurement 
and disease duration and number of blood transfusions. However multivariate 
analysis showed only the number of blood transfusion is correlated with patient 
CIMT measurement. Increased in the number of blood transfusion by 100 times 
will increase the mean CIMT by 1.0mm.  
 
Conclusion: The CIMT measurement among thalassemia patient is 
significantly higher compared to general population and it is associated with the 
numbers of blood transfusion being received. 
 
Dr Juhara Haron : Supervisor 
AP Dr Ariffin Nasir : Co- supervisor 













Specially dedicated to: 
My supportive and loving wife, Nur Asyilla Che Jalil for her patience and all 
her sacrifices for support me in completing my master programme. 
My daughter, Adriana Zehra who has been growing up with a busy father and 
for being a very good and patience girl. 
My mother, Zainab Mohammed Hashim who has given me strength and 
exemplary to lead a happy and wonderful life.  
My father, Samsudin Omar who has been very supportive throughout my 
whole life. Thank you for all your guidance and previous advices. 


















The author would like to take this opportunity to thank, first of all, Dr Juhara 
Haron, who is the author’s supervisor, for all the time she spent on this dissertation 
project. Her guidance and constant advice and encouragement had greatly helped the 
author in completing this dissertation. 
The author would also like to thank Associate Professor (Dr)  Ariffin Nasir 
from Department of Paediatric and Dr Rosnah Bahar, from Haematology Unit, 
HUSM for all the advices and guidance given from the beginning till the end of the 
this dissertation project. 
The author would also like to thank Dr Nik Munirah Nik Mahdi, the Head, 
Department of Radiology and all the other lecturers, Department of radiology, 
Hospital Universiti Sains Malaysia, namely Associate Professor (Dr) Mohd Ezane 
Aziz, Associate Professor (Dr) Mohd Shafei Abdullah, Associate Professor (Dr) 
Abdul Kareem, Dr Salmah @ Win Mar, Dr Ahmad Helmy Abdul Karim, Dr Rohsila 
Muhamad, Dr Norzila Tendot Abu Bakar, Dr Khairil Amir Sayuti and not to forget 
the former lecturer,  Associate Professor (Dr) Noreen Nurfarahin Lee Abdullah and 
Dr Nor Azam Mahmud, in giving guidance, teaching and valuabe comments during 
the proposal and progress of this study. 
Special thanks also to all the badge-mates, senior and juniors of the Master of 
Medicine (Radiology) programme. Last but not least the author would like to thank all 
the staffs in the Department of Radiology and Department of Paediatric, Hospital 
Universiti Sains Malaysia for all their help and patience. 
iv 
 
TABLE OF CONTENT 
Dedication ii 
Acknowledgement iii 
Tables of Content iv 
List of Figures  vii 
Lists of Tables viii 
Abbreviations ix 
Abstract 
          Bahasa Malaysia 









CHAPTER 2 – LITERATURE REVIEW 5 
2.1 Anatomy of Common Carotid Artery 5 
          2.1.1 Vascular Anatomy 5 
          2.1.2 Normal variants 6 
          2.1.3 Normal Arterial Wall Structures 8 
          2.1.4 Normal Vascular Endothelium Layer Structure and Functions 11 
2.2 Atherosclerosis 15 
          2.2.1 Early Lesions (Type I and II) 15 
          2.2.2 Preatheroma/ Intermediate Lesions (Type III) 16 
          2.2.3 Advance Atherosclerotic Plaques (Atheroma-IV,  
                   Fibroatheroma-Va, Calcific-Vb and Fibrotic-Vc) 
17 
2.3 Thalassemia 21 
2.4 Hypercoagulability State in Thalassemia Patient 24 
2.5 Radiological Investigation of Carotid Diseases 29 









CHAPTER 3 - OBJECTIVES 33 
3.1 General Objectives 33 
3.2 Specific Objectives 33 
3.3 Hypothesis 33 
  
CHAPTER 4 – VALIDATION STUDY 34 
4.1  Introduction 34 
4.2  Objectives 34 
4.3  Methodology 34 
4.4  Flow Chart 37 
4.5  Result          38 
4.6 Discussion 39 
  
CHAPTER 5 – METHODOLOGY 41 
5.1   Study design 41 
5.2   Reference Population 41 
5.3   Source population 41 
5.4   Study Period 41 
5.5   Place of Study 41 
5.6   Ethical Consideration 42 
5.7   Sampling Method 42 
5.8   Inclusion and Exclusion Criteria 
          5.8.1 Inclusion Criteria 




5.9   Research Tools 43 
5.10 Sample Size Calculation 44 
5.11 Data Collection and Statistical Analysis 45 
          5.11.1 Objective 1 
          5.11.2 Objective 2    
 45 
50 

































CHAPTER 6 - RESULTS 52 
6.1 Demographic Data 52 
6.2 Comparison CIMT measurement between thalassemia and non- thalassemia 
      group 
57 
6.3 Association between CIMT and patient’s age, disease duration, numbers of 





CHAPTER 7 – DISCUSSION 71 
7.1 Overview  71 
7.2 Demographic Characteristic 73 
7.3 Comparison between CIMT measurements and the non- thalassemia group  75 
7.4 Correlation between thalassemia CIMT measurement and patient’s number 
     of blood transfusions 
76 
7.5 Correlation between thalassemia CIMT measurement and serum ferritin level 79 
7.6 Correlation between thalassemia CIMT measurement with patient’s age and 
      disease duration 
81 
  
CHAPTER 8 – SUMMARY AND CONCLUSION 83 
7.0 Summary and Conclusion 83 
  
CHAPTER 9– LIMITATIONS AND RECOMMENDATIONS 84 
9.1 Limitations  84 







LIST OF FIGURES 
 
  Page 
Figure 2.1 Most common appearance of aortic arch. 6 
Figure 2.2 Normal variant of the aortic arch and origin of 
the common carotid artery. 
7 
Figure 2.3 Normal arterial wall structure. 10 
Figure 2.4 Histological examples of atherosclerotic plaque 
types classified according to the American 
Heart Association criteria. 
19 
Figure 2.5 Types of beta thalassemia. 23 
Figure 2.6 Types of alpha thalassemia. 24 
Figure 2.7 B-mode sonography of common carotid artery 
showing near wall and far wall. 
32 
Figure 5.1 Patient positioning for the ultrasound 
examination. 
47 
Figure 5.2 Sonographic carotid intima- media thickness 
measurement on the far wall, proximal to the 
carotid bulb. 
49 
Figure 6.1 Gender distribution among non- thalassemia 
group 
53 
Figure 6.2 Race distribution among non- thalassemia 
group 
53 
Figure 6.3 Mean age among non- thalassemia group 54 
Figure 6.4 Gender distribution among thalassemia group 55 
Figure 6.5 Race distribution among thalassemia group 55 
Figure 6.6 Mean age among thalassemia group 56 
Figure 6.7 Mean CIMT among non- thalassemia group 58 
Figure 6.8 Mean CIMT among thalassemia group 59 
Figure 6.9 Age against mean CIMT 62 
Figure 6.10 Disease duration against mean CIMT 63 
Figure 6.11 Numbers of blood transfusion against mean 
CIMT 
64 
Figure 6.12 Serum ferritin against mean CIMT 65 
Figure 6.13 Assumption: Unstandardized residual against 
unstandardized predicted value 
68 
Figure 6.14 Assumption: Normality of residual 69 
Figure 6.15 Assumption: Unstandardized residual against 




LIST OF TABLES 
 
  Page 
Table 2.1 Functions of arterial smooth muscle cells 11 
Table 2.2 Functions of endothelial cells. 14 
Table 2.3 Causes of hypercoagulable state in thalassemia 
patient. 
28 
Table 4.1 Intra-observer reliability with Case 1 ICC (1): one-
way random model, single measure. 
38 
Table 4.2 Intra-observer reliability with Case 3 ICC (1): two-
way mixed model, single measure. 
39 
Table 6.1 Mean CIMT between thalassemia and non- 
thalassemia group (n=80) 
60 
Table 6.2 Thalassemia patient mean disease duration, serum 
ferritin level and numbers of blood transfusion 
61 
Table 6.3 Association between age, disease duration, numbers 
of blood transfusion and serum ferritin level and 
mean CIMT among thalassemia patient (n=40) using 
simple linear regression test 
66 
Table 6.4 Factor associated with mean CIMT among 
thalassemia patient (n=40) using multiple linear 
regression test 
67 



















 AHA   American Heart Association 
AT III  Antithrombin III 
CIMT  Carotid intima-media thickness 
CNS   Central nervous system 
DVT   Deep vein thrombosis 
eNOS  endothelial nitric oxide synthase 
HUSM  Hospital Universiti Sains Malaysia 
LDL   Low-density lipoprotein 
 NO   Nitrous oxide 
ROS   Reactive oxygen species 









Tajuk: Kajian tentang ketebalan ‘carotid intima-media’ di kalangan pesakit 
thalassemia di HUSM. 
 
Latarbelakang: 
Jangka hayat pesakit thalassemia sekarang dapat dilanjutkan dengan adanya 
perkembangan pesat dalam teknologi perubatan dan prasarana kemudahan kesihatan. 
Akibatnya, timbul komplikasi- komplikasi baru dikalangan pesakit thalassemia ini dan 
diantara yang meningkat ialah komplikasi salur darah tersumbat (thromboembolism). 
Kajian menunjukkan ketebalan ‘carotid intima-media’(CIM) yang diukur menggunakan 
mesin ultrasound dapat memberi gambaran dan stratifikasi tentang risiko serangan sakit 
jantung dan angin ahmar. Kajian terdahulu mensyorkan kajian CIM ini dilakukan keatas 
pesakit thalassemia sebagai alat diagnostik awal dan juga dapat mengetahui risiko untuk 
mendapat komplikasi salur darah tersumbat. 
 
Objektif: 
 Bertujuan untuk mengetahui perbezaan ketebalan CIM diantara pesakit thalassemia 
dengan populasi bukan thalassemia. Kajian juga dilakukan untuk mengetahui hubungan 
diantara ketebalan CIM pesakit dengan umur, jangkamasa penyakit, bilangan transfusi 
darah dan kepekatan serum ferritin. 






 Kajian telah dijalankan di Jabatan Radiologi, Hospital Universiti Sains Malaysia 
selama 19 bulan daripada Januari 2013 hingga Ogos 2014. Ketebalan CIM diukur oleh 
seorang penyelidik dengan menggunakan transduser selanjar 18MHz (Acuson S2000 
Siemens). Semua pesakit thalassemia yang sedang menerima rawatan atau rawatan 
susulan di HUSM dan bersetuju untuk mengikuti kajian ini telah diambil untuk kajian 
ini. Selain itu umur pesakit, jangkamasa penyakit, bilangan transfusi darah dan paras 
serum ferritin pesakit thalassemia juga diambil dan direkodkan. 
 
Keputusan: 
 Seramai 80 subjek terlibat dalam kajian ini dimana jumlah subjek thalassemia dan 
bukan thalassemia adalah sama. Nilai purata ketebalan CIM pesakit thalassemia adalah 
0.45± 0.1mm dan nilai purata ketebalan CIM populasi bukan thalassemia adalah 0.32± 
0.08mm. Terdapat perbezaan yang signifikan secara statistik diantara nilai purata 
ketebalan CIM pesakit thalassemia dengan populasi bukan thalassemia. Kajian juga 
mendapati terdapat hubungkait yang signifikan diantara bilangan transfusi darah dengan 
ketebalan CIM pesakit thalassemia. Kenaikan 100 kali bilangan transfusi darah akan 
mengakibatkan kenaikan ketebalam CIM pesakit thalassemia sebanyak 1.0mm. 
 
Kesimpulan: 
 Berdasarkan keputusan ketebalan CIM yang telah dibuat, pesakit thalassemia 
mungkin berisiko lebih tinggi berbanding dengan populasi bukan thalassemia untuk 
mendapat serangan jantung dan angin ahmar dan ianya berkait rapat dengan bilangan 











 Thalassemia patient lifespan nowadays has been increased significantly compared to 
previously due to the advancement of medical treatment and better healthcare system. 
As a result, more transfusion-related complications are seen, and one of the rising trends 
is the thromboembolic complication. Studies has shown that ultrasound measurement of 
carotid intima-media thickness (CIMT) can be used as a surrogate marker for future 
cardiovascular event and is recommended to be done in thalassemia patient as early 
diagnostic tool and for vascular risk stratification. 
 
Objectives: 
 To compare CIMT measurement between thalassemia patients in HUSM with the 
non- thalassemia population and to find any association between CIMT measurement 




 A cross sectional study was done over a period of 19 months from January 2013 until 
August 2014. A single operator performed the ultrasound examination using 18 Mhz 
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linear array transducer (Siemen Acuson S2000) at Department of Radiology, Hospital 
Universiti Sains Malaysia (HUSM). All thalassemia patient who is receiving treatment 
and follow-up at HUSM and consented for the examination, were subjected to the 
measurement of their carotid intima-media thickness (CIMT). Patient age, disease 
duration, numbers of blood transfusion and serum ferritin level were obtained and 
recorded. The same numbers of healthy subject were recruited from the general 
population and their CIMT were also recorded. 
 
Result: 
 A total of 80 subjects were included in this study with the equal number of 
thalassemia patients and the non- thalassemia population. The mean value of CIMT for 
the non- thalassemia population was 0.32± 0.08mm and that of thalassemia patient was 
0.45± 0.10mm. Independent t-test showed statistically significant difference between 
these two measurements (p<0.001). On univariate analysis, there was a strong 
correlation between thalassemia CIMT measurement and disease duration and number 
of blood transfusions. However multivariate analysis showed only the number of blood 
transfusion was significantly correlated with patient CIMT measurement. Increased in 




 The finding of higher mean value of CIMT in thalassemia patient might be suggestive 
for an increased in future cardiovascular and cerebrovascular event in thalassemia 
patient compared to non- thalassemia population and it is significantly associated with 






Thalassemia is classified as a group of congenital hereditary blood disorders in 
which the anomalies are within the synthesis of the chains of haemoglobin. The total 
annual incidence of symptomatic individuals is estimated at 1 in 100,000 throughout 
the world and in Malaysia, it is estimated about 4.5% of its population are 
heterozygous carriers for beta- thalassemia and the couples are at risk of having beta 
thalassemic child about 2.1/1000 births annually (George, 2001). Clinical 
presentations of thalassemia range from totally asymptomatic individuals to severe 
anaemia which needs regular blood transfusion. It is estimated that about 4,800 
thalassemia major patients in Malaysia which need regular blood transfusion 
(Elizabeth and Ann, 2011).  
 
Common problem encountered by thalassemia major patient from their 
chronic anaemic state is tissue iron deposition as a result from the frequent blood 
transfusion and increased in gastrointestineal iron absorption. As a consequence, toxic 
iron will accumulate within liver, heart, spleen and endocrine organs. Chelation 
therapy had been commenced to counter iron overload in thalassemia patient and 
desferoxamine mesylate has been the standard treatment for iron chelation therapy for 
decades (Delea et al., 2007). Although current thalassemia patients’ survival has 
increased due to chelation therapy, cardiovascular complications are still common 
(Hahalis et al., 2008) and about 70% of all thalassemic deaths are due to heart failure 
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and arrhythmias (Borgna-Pignatti et al., 2004). This may be due to issue of 
compliancy because of the discomfort during the iron chelating therapy administration 
and due to its high cost (Delea et al., 2007; Dahlui et al., 2009; Viprakasit et al., 
2009). The compliancy of desferoxamine usage had been shown to reduce the serum 
ferritin level as well as cardiac complication (Wolfe et al., 1985).   
 
Besides that, incidence of vascular complications has been reported in 
thalassemia patients, mainly attributed by the hypercoagulable state and vascular 
dysfunction (Hahalis et al., 2008). Atherosclerosis is a formation of an atherosclerotic 
plaque within the arterial lumen. It usually started as lipid-filed macrophages or foam 
cells in the early phase which can be replaced by collagen fibres in later stage. As the 
size of the atherosclerotic plaque increases, it can cause narrowing of the vessel 
lumen.  The thickening of the luminal wall can be detected by several imaging 
modalities especially the intima-media complex which also been called as carotid 
intima media thickness (CIMT). 
 
CIMT can be measured by using ultrasound, computed tomography (CT) scan 
or magnetic resonance imaging (MRI). Ultrasound examination is by far the most 
preferred technique as it is non-radiating and relatively inexpensive. CT scan 
measurement is highly reproducible compared to ultrasound and its measurement can 
be considered as tomographic equivalent of sonographic CIMT (Saba et al., 2008). 
However the radiation hazard from the examination limits its daily usage. MRI 
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examination is another examination which is potential to have higher reproducibility 
(Underhill et al., 2006). However the availability is usually limited compared to 
ultrasound and the cost is much higher.  
 
 Several studies have shown that sonographic carotid intima media thickness 
(CIMT) measurement is increased in thalassemia patients indicating premature 
atherosclerosis. The same studies also shown that sonographic CIMT measurement in 
thalassemic patients’ are correlated with patients’ age (Tantawy et al., 2009), disease 
duration (Dogan and Citak, 2011) and serum ferritin level (Tantawy et al., 2009; 
Ismail and El-Sherif, 2010; Dogan and Citak, 2011). Sonographic CIMT 
measurement, which is a recognised surrogate marker for future cardiovascular events  
(Bots et al., 1997) is recommended to be done in beta thalassemia patients as a non-
invasive early diagnostic tool (Ismail and El-Sherif, 2010; Dogan and Citak, 2011)  
and for vascular risk stratification (Tantawy et al., 2009).   
 
There are few sonographic CIMT measurement studies done on thalassemia 
patients worldwide however there is no similar study has yet to be done in Southeast 
Asia, particularly Malaysia which mainly comprised of HbE β-thalassemia, which is a 
structural β-globin Hb variant with a β+ phenotype (George, 2013). HbE β-
thalassemia shows highest frequencies in Asia such as India, Bangladesh, Thailand, 
Laos, Cambodia (Olivieri et al., 2011) and also in Malaysians’ Malay population 
(George, 2013). By doing this study, it is hoped that the local thalassemia CIMT 
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measurement can be measured and compared with the normal population. Any 
difference in the mean and standard deviation will be analyzed and any increment in 
the CIMT would indicate subclinical atherosclerosis and increased risk of having 
future thrombosis event. If there is evidence of subclinical atherosclerosis in the local 
thalassemia population, than perhaps there would be a role of anti-thrombolytic agent 
in thalassemia patient in the future. Any significant correlation between patient CIMT 
with patient’s age, disease duration, number of blood transfusion and serum ferritin 




2.0 LITERATURE REVIEW 
 
 
2.1 Anatomy of the common carotid artery  
 
Both right and left common carotid arteries differ in length and in their mode 
of origin. There are many variants besides the common pattern. The knowledge of the 
normal common carotid artery anatomy and its variants are important during the 
ultrasound assessment. 
 
2.1.1 Vascular anatomy 
The brain received its blood supply mainly from 4 main vessels, right and left 
internal carotid arteries and right and left vertebral arteries. The internal carotid artery 
derived from common carotid artery on each side of the neck. The right common 
carotid artery derives from the brachiocephalic trunk which is the first branch of arch 
of aorta while the left common carotid artery derived directly from aortic arch in the 
superior mediastinum (Figure 2.1). The right common carotid artery has cervical part 
while left common carotid artery has cervical and thoracic part (Standring, 2008). 
 
The brachiocephalic trunk travels superiorly, slightly posterior from the aortic 
arch to the right of the neck for about 4 to 5cm in length before dividing into right 
common carotid artery and right subclavian artery at the upper border of right 
sternoclavicular junction (Zwiebel, 2000). The left common carotid artery travels 
upwards from the aortic arch and passes beneath left sternoclavicular joint. Both 
common carotid arteries then divides into internal and external carotid arteries at the 
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level of upper border of thyroid cartilage (Zwiebel, 2000). Both common carotid 
arteries do not give collateral branches.  
 
2.1.2 Normal variants. 
There are many normal variants of the origin of these vessels (Butler et al., 
2012). The most common appearance of the aortic arch and it normal variations are 
shown in figure 2.1 and figure 2.2. The knowledge of the normal variants is important 




























Figure 2.2: Normal variant of the aortic arch and origin of the common 
carotid artery. Key: RS- right subclavian artery, RC- right 
common carotid artery, BT – brachiocephalic trunk LC- left 
common carotid artery, LS- left subclavian artery and LVA- left 
vertebral artery. (Adapted from Butler et al., 2012) 















2.1.3 Normal arterial wall structure 
Traditionally, based on the basis of size and characteristics of tunica media, 
there are 3 different types of arteries (Pawlina and Ross, 2011) which are the large 
arteries, medium arteries and small arteries or arteriololes. Common carotid artery is 
categorized under large artery and has 3 distinct layers which are the intima or the 
epithelial lining of the artery, media or muscular layer and adventitia. The intima is 
the innermost layer, followed by media which is the middle layer and adventitia, the 
outermost layer (Figure 2.3).  
 
The tunica intima consist mainly of three component; the endothelium which 
is a single layer of squamous epithelial cell; a thin layer of extracellular cell called 
basal lamina which composed of collagen, proteoglycan and glycoprotein; and lastly 
the subendothelial layer which consists of loose connective tissue. Smooth muscle cell 
occasionally can be found within the loose connective tissue. This subendothelial 
layer contained sheet like layer or lamella of fenestrated elastic material called the 
internal elastic membrane. These fenestrations enable substances to diffuse readily 
through the layer and reach cells deep within the wall of the vessel.  
 
The tunica media, or middle layer, consists primarily of circumferentially 
arranged layers of smooth muscle cells (Standring, 2008). This layer has variable 
amounts of elastin, reticular fibers, and proteoglycans which is interposed between the 
smooth muscle cells of the tunica media. It extends from the internal elastic 
membrane to external elastic membrane and is relatively thick. The external elastic 
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membrane is a layer of elastin that separates the tunica media from the tunica 
adventitia. The sheets or lamellae of elastin are fenestrated and arranged in circular 
concentric layers.  
 
The tunica adventitia, or outermost connective tissue layer, is composed 
primarily of longitudinally arranged collagenous tissue and a few elastic fibers. It will 
gradually merge with the loose connective tissue surrounding the vessels. This tunica 
adventitia is relatively thin. Most tunica adventitia layers of large arteries contains a 
system of vessels that supplies blood to the vascular walls themselves called the vasa 
vasorum, as well as a network of autonomic nerves called nervi vascularis that control 
contraction of the smooth muscle in the vessel walls. The main cell in the adventitia 
layer is the smooth muscle cells. Their main function is for structural support of the 
artery. They regulate the size of the arterial lumen and hence the blood flow and blood 
pressure by their contractility responses. The smooth muscle cells also responsible for 
synthesis of all constituents of the arterial wall. It is also capable of endocytosis of 
foreign materials and lipoproteins. Besides that, the smooth muscle cells also produce 
all of the extracellular components of the tunica media. The function of smooth 

















                      Table 2.1:   Functions of arterial smooth muscle cells 
1. Structural support 
2. Contractile response 











2.1.4  Normal vascular endothelium layer structure and functions 
 
The endothelium layer is formed by a continuous layer of flattened, elongated, 
and polygonally shaped endothelial cells that are aligned with their long axes in the 
direction of the blood flow. At the luminal surface, they express a variety of surface 
adhesion molecules and receptors such as low-density lipoprotein, insulin, and 
histamine receptors. Endothelial cells have many functions (Table 2.2). It plays an 
important role in blood homeostasis in which these cells can change their functional 
properties in response to various stimuli. This process, known as endothelial 
activation, is also responsible for the pathogenesis of many vascular diseases 
particularly atherosclerosis. Inducers of endothelial activation include bacterial and 
viral antigens, cytotoxins, complement products, lipid products, and hypoxia. 
Activated endothelial cells exhibit new surface adhesion molecules and produce 
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different classes of cytokines, lymphokines, growth factors, and vasoconstrictor and 
vasodilator molecules, as well as molecules that control blood coagulation. 
Endothelial cells also participate in the structural and functional integrity of the 
vascular wall.  
 
Apart from that, endothelial cells are also active participants in a variety of 
interactions between the blood and underlying connective tissue and are responsible 
for many properties of the vessels. First, endothelial cells exhibit a selective 
permeability barrier which allows selective movement of small and large molecules 
from the blood to the tissues and from the tissues to the blood. This movement is 
related to the size and charge of the molecules. Through a process called simple 
diffusion, small hydrophobic (lipid-soluble) molecules such as oxygen or carbon 
dioxide can readily pass through the permeable lipid bilayer of the endothelial cell 
membrane. However, water and hydrophilic (water-soluble) molecules such as 
glucose, amino acids and electrolytes cannot diffuse across the endothelial cell 
membrane and these molecules and solutes have to be actively transported. Secondly, 
the endothelial layer functions as a nonthrombogenic barrier between blood platelets 
and subendothelial tissue which is done by producing anticoagulants and 
antithrombogenic substances. Normal endothelium does not support the adherence of 
platelets or the formation of thrombi on its surface. However, damaged endothelial 
cells cause them to release prothrombogenic agents such as von Willebrand factor or 
plasminogen-activator inhibitor to promote thrombus formation. The modulation of 
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blood flow and vascular resistance is achieved by the secretion of vasoconstrictors 
such as endothelins, angiotensin-converting enzyme, prostaglandin, thromboxane and 
vasodilators such as nitrous oxide (NO).  
 
The contraction and relaxation of smooth muscle cells in the tunica media 
influencing local blood flow and pressure also is being controlled by the endothelium 
layer. Shear stress produced during the interaction of blood flow with vascular 
endothelial cells initiates nitric oxide-derived relaxation of blood vessels. 
Endothelium-derived nitric oxide is one of several critical regulators of cardiovascular 
homeostasis. It regulates the blood vessel diameter, inhibits monocyte adhesion to 
dysfunctional endothelial cells, and maintains an antiproliferative and anti-apoptotic 
environment in the vessel wall. Nitric oxide is an endogenous vasodilatory gas which 
continuously being synthesized in endothelial cells by endothelial nitric oxide 
synthase (eNOS). It acts as an anti-inflammatory agent under normal physiologic 
conditions, although its overproduction induces inflammation. Nitric oxide is also 
involved in immune reactions, a potent neurotransmitter in the nervous system, and 
also contributes to the regulation of apoptosis.  
 
Other function of endothelial cell includes regulation and modulation of the 
immune responses. It also synthesizes, metabolizes and secretes many substances, 
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such as prostacyclin, angiotensin-converting enzyme, clotting factor VIII and 
lipoprotein lipase. 
 
Table 2.2: Functions of endothelial cells 
1. Blood compatible container 
2. Selective permeability barrier 
3. Synthetic/ metabolic/ secretory function 
- Angiotensin-converting enzyme 
- Factor VII 
- Plasminogen 




- Collagen (type IV) 
- Α-2-macroglobulin 
- Lipoprotein lipase 
- Hormone receptors 








 2.2 Atherosclerosis 
Atherosclerosis is the process of atherosclerotic plaque formation within the 
arterial lumen. Atherosclerotic plaques can be characterized by tunica intimal 
thickening due to progressive accumulation of lipids together with numerous cellular 
and molecular components such as smooth muscle cells (SMC), lipid-filled 
macrophages, monocytes, T and B lymphocytes, erythrocytes, and platelets 
(Nicolaides et al., 2011). American Heart Association (AHA) Committee on Vascular 
Lesion has divided plaques into six stages according to the plaque composition and 
morphology based on histologic studies of human vessels, mainly coronary and aortic 
arteries obtained at autopsy.  
 
 
 2.2.1 Early Lesions (Types I and II) 
These plaques appear during the first decades of life and usually do not cause 
substantial luminal stenosis. In type I plaques, the histological changes are minimal, 
which consist of isolated groups of lipid-filled macrophages or foam cells that are 
visible only with microscopic examination (Figure 2.4). These are in contrast to type 
II plaques or fatty streaks which are visible on gross examination and contain 
increased numbers of foamy macrophages. It will become stratified into layers 
together with some foamy smooth muscle cells (Figure 2.4). The main source of 
plaque lipids is the circulating LDL particles that become entrapped within the 
subendothelial layer as evidence by the strong similarity between the chemical 
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composition of the low-density lipoprotein (LDL) particles and plaque lipids. The 
process in which LDL particles can appear within the vessel wall is either by passive 
diffusion through the endothelium or by receptor-mediated endocytosis. 
Subsequently, through ionic interactions between the apolipoprotein-B of the LDL 
particle and matrix proteoglycans, collagen fibers, and fibronectin found in the vessel 
wall, retention of LDL particles within the vessel wall will occur. The trapped LDL 
particles will then undergo extensive modifications such as oxidation, proteolysis, 
aggregation, and lipolysis. Minimally oxidized LDL particles (mmLDL) are 
recognized by the LDL receptor, and their accumulation will stimulate endothelial 
cells to promote recruitment of monocytes and lymphocytes to the vessel wall. 
Severely oxidized LDL particles in contrast, can only be recognized by scavenger 
receptors that are expressed on macrophages and vascular smooth muscle cells. The 
uptake of oxidized LDL will cause formation of foam cells (Figure 2.4). 
 
 
 2.2.2    Preatheroma/Intermediate Lesions (Type III) 
Type III plaques have a histological appearance that is in between the early 
fatty streaks and the first advanced lesion type or atheroma. However, it is not known 
how the plaques progress from one stage to the other, whether it progress linearly or 
not. In type III plaques, organized histological layers can be seen. Foamy cells are 
present at the luminal side with tissue degeneration region seen in the middle layer 
and scattered extracellular lipids noted at the base of the plaque (Figure 2.4). Type III 
plaques contain more free cholesterol, fatty acids, triglycerides, sphingomyelin, and 
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lysolecithin than type II plaques. An intermediate type of plaque can directly 
transform into an advanced and more complicated lesion. 
 
 
2.2.3 Advanced Atherosclerotic Plaques (Atheroma-IV, Fibroatheroma-Va, 
Calcific-Vb and Fibrotic-Vc) 
In type IV plaque or atheroma, there is abundant accumulation of extracellular 
lipids is seen. The lipids form a consolidated core located deeply within the intima 
and disorganizes the extracellular matrix. The region of the thickened intima between 
the lipid core and the endothelial surface contains smooth muscle cells, macrophages 
with and without lipid droplets, T lymphocytes and mast cells (Figure 2.4). 
Proteoglycan will be secreted by the smooth muscle cells in and few collagen fibers 
may gradually thicken at the region above the lipid core. At the base of the atheroma, 
cell death and formation of a necrotic core will occurs which is rich in cellular debris 
and crystalline cholesterol. Atheroma usually do not cause severe luminal narrowing, 
however there are susceptible to fissure formation and ruptures to become a 
complicated plaque due to their surface composition. 
 
Fibroatheromas or type Va plaques have a thick layer of fibrous connective 
tissue. It mainly contains collagen fibers and rough endoplasmic reticulum–rich 
smooth muscle cells at the luminal side of the intima which is called the fibrous cap. 
It separates the lipid core from circulating blood constituents. The capillaries at the 
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borders of the lipid core may be larger and more numerous compared to those found 
in type IV plaques. 
 
Type Vb plaques or calcified plaques is characterized by increased in its 
mineralization. In type Vc or fibrotic lesions, the intima thickening is primarily due to 
accumulation of collagen fibers instead of lipid accumulation. Type V plaque can 
suddenly transform to type VI plaque with formation of surface defects like erosions, 





Figure 2.4: Histological examples of atherosclerotic plaque types classified 
according to the American Heart Association criteria (Adapted 
from Nicolaides et al., 2011).  
(a) A crescent-shaped type I intimal thickening. Pgc=proteoglycan intima layer, me= 
musculoelastic intima layer, M=media, A=adventitia, lumen=lumen of the artery 
(b) A type II (progression-prone fatty streak) lesion. Macrophage foam cells (fc) 
occupy the intima at the junction of the proteoglycan (pgc) and musculoelastic (me) 
intima layers, e=endothelial cells at the artery lumen, M=media, A=adventitia.  
(c) A type III (preatheroma) lesion. Extracellular lipid (arrows) is pooled in the 
musculoelastic layer (me). Smooth muscle cells, normally closely packed, are 
separated, compressed, and attenuated by the extracellular lipid. Macrophage foam 
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cells (fc) are some distance above the pooled extracellular lipid, endothelial cells (e) 
at the artery lumen, pgc= proteoglycan intima, M= media, A= adventitia.  
(d) A type IV (atheroma) lesion. In addition to all the changes seen in type IIa and III 
lesions, a massive aggregate of extracellular lipid (lipid core) occupies the 
musculoelastic layer (me). Macrophage foam cells (fc) are above the lipid core. Pgc= 
proteoglycan intima layer, M=media, A=adventitia 
(e) A type V (fibroatheroma) lesion in the distal part of the abdominal aorta. The part 
of the lesion above the lipid core and above the layer of macrophage foam cells (fc) 
consists of dense bands of collagen, endothelial cells (e) at the artery lumen, M= 
media,  
(f) A type VI (complicated) lesion in the distal recruited through the activated 
endothelium differentiate into macrophages. Several endogenous and microbial 
molecules can ligate pattern-recognition receptors on these cells, inducing activation 
and leading to the release of inflammatory cytokines, chemokines, oxygen and 
nitrogen radicals, and other inflammatory molecules and, ultimately, to inflammation 

















Thalassemia syndromes are inherited disorders due to abnormal α or β-globin 
biosynthesis. The reduce supply of globin will reduce production of haemoglobin 
tetramers, leading to hypochromia and microcytosis. The synthesis of the unaffected 
globins proceeds at normal rate will cause unbalanced accumulation of alpha or beta 
subunits.  Normally all four alpha genes and both beta genes are active in the 
production of globin chains. In beta thalassemia, synthesis of the beta chain is 
defective where as in alpha thalassemia, the synthesis of the alpha chain that is 
defective. Beta thalassemia is common in the Mediterranean region and in portions of 
Africa, Asia, the South Pacific, and India while alpha thalassemia is most common in 
Southeast Asia. Thalassemia patients have a wide spectrum of clinical presentations, 
ranging from totally asymptomatic to severe anaemia which need regular blood 
transfusion. This depends on the degree to which the synthesis of the affected globin 
is impaired, altered synthesis of other globin chains and coinheritance of other 
abnormal globin alleles (Longo, 2013).  
 
In beta thalassemia, point mutations or a partial deletion of chromosome 11 
cause defective synthesis of the beta chain. Over 100 mutations have been identified. 
Normally alpha and beta globin chains are made approximately in equal amounts. 
When beta globin chains are in short supply or absent, as in beta thalassemia, alpha 
chains are in excess. The excess alpha chains combine with other available beta 
family globin chains (delta or gamma) to form increased amounts of Hgb A2 (α2 δ2) 
and Hgb F (α2 γ2). Hgb Barts (γ4) or tetramers of excess gamma chains may also 
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form (Figure 2.5). Because of the reduced amounts of haemoglobin tetramers, all beta 
thalassemia haemoglobin are characterised by hypochromic and microcystosis. In 
heterozygotes or known as beta thalassemia trait, this is the only abnormality seen and 
the anaemia is usually minimal. In more severe form of homozygous state, there will 
be highly insoluble unpaired alpha chains due to unbalanced alpha and beta-globin 
accumulation. This in turn will form toxic inclusion bodies that kill developing 
erythroblast in the marrow. Few erythroblasts will survive and mature and it will then 
bear a burden of inclusion bodies that are detected in the spleen. The red blood cell 
life span will be reduced leading to haemolytic anaemia. Marrows will response with 
increased production of erythroblast however the anaemia will still persist due to 
ineffective erythropoiesis. Based from the abnormal genetic mutation inherited and 
clinical syndromes, four phenotypes of beta-thalassemia had been categorised: beta-
thalassemia carrier, beta-thalassemia trait, beta-thalassemia intermedia and beta-
thalassemia major. Beta-thalassemia carrier and trait are usually asymptomatic, 
whereas beta-thalassemia major needs frequent blood transfusion. Unlike thalassemia 
major, beta-thalassemia intermedia patients usually does not need frequent blood 
transfusions and commonly presented later, during their early adulthood period.  
 
One to four alpha genes may be deleted in alpha thalassemia disorders. The 
clinical manifestations of alpha thalassemia vary with the number of alpha-chain 
genes that are deleted from chromosome 16. If only one alpha gene is deleted, no 
hematologic abnormalities are seen. This is known as a silent carrier state. If two 
alpha genes are deleted, either homozygous (a-/a-) or heterozygous (--/aa), the 
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condition is alpha thalassemia trait. The heterozygous type is encountered in 
Southeast Asian populations, but is rare in Afro-Americans. Alpha thalassemia trait 
results in microcytosis, hypochromia, and mild anaemia. If three alpha genes are 
deleted (--/-a), there will be an accumulation of unpaired beta chains and are soluble 
enough to form β4 tetramers called hemoglobin H (HbH) (Figure 2.6). Patient with 
hemoglobin H disease usually will behave like thalassemia intermedia, characterised 
by moderately severe haemolytic anaemia but milder ineffective erythropoiesis. It 
also common for the patient to survive to mid-adult life without needing blood 
transfusion. If all four of the alpha genes are deleted, it is called hemoglobin Barts 
which is incompatible with life and usually results death in utero. The red blood cells 
contain only Bart's haemoglobin, a tetramer of gamma chains which is incompatible 
with life. This condition which also known as hydrops fetalis is usually encountered 
in Asian and African population. 
 
 










2.4 Hypercoagulability State in Thalassemia Patient 
Due to the better health care support, current thalassemia patient lives longer 
compared previously. As a result, new complication were identified in this type of 
patient and the commonest problem that had been increasingly recognised is 
thromboembolic events (Taher et al., 2008) (Panigrahi and Agarwal, 2007). An Italian 
multicentre study (Borgna Pignatti et al., 1998) revealed that 27 of 683 (3.95%) 
thalassemia major and 5 of 52 (9.61%) thalassemia intermedia patient developed 
thromboembolic events. About half the events involved central nerve system (CNS) 
location, followed by deep vein thrombosis (DVT) (25%), pulmonary (9.3%), portal 
(6.3%) and intracardiac (6.3%). Another study done in Mediterranean regions and 
Iran (Taher et al., 2006) showed that 146 out of 8860 (1.65%) thalassemia patient had 
experienced thromboembolic event, 61 with thalassemia major (0.9%) and 85 with 
thalassemia intermedia (3.9%). According to the study, the highest occurrence of 
thromboembolic events that occur in thalassemia were deep vein thrombosis (32%), 
